Sanger Sequencing Market would rocket up to USD 7.47 billion by 2029

An oligonucleotide sequencing primer that binds to the DNA next to the region of interest is used in Sanger sequencing to focus on a particular area of the template DNA. W Sanger sequencing uses chemical replicas of the four DNA nucleotides to determine the sequence. Dideoxyribonucleotides (ddNTPs) are these analogues, which lack the 3' hydroxyl group necessary for the 5' to 3' elongation of a DNA polynucleotide chain.

Data Bridge Market Research analyses that the sanger sequencing market which was USD 1.92 billion in 2021, would rocket up to USD 7.47 billion by 2029, and is expected to undergo a CAGR of 18.50% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Read More:
https://www.databridgemarketresearch.com/reports/global-sanger-sequencing-market

Market Definition

The sanger technique of DNA sequencing relies on the random incorporation of chain-terminating dideoxynucleotides by DNA polymerase during in vitro DNA replication and uses electrophoresis. However, for smaller-scale initiatives and for validating the outcomes of deep sequencing, the sanger approach is still widely used. It can still create DNA sequence reads of more than 500 nucleotides and maintain accuracy levels around 99.99 percent, giving it an edge over short-read sequencing methods (like Illumina).

Drivers

Technological advancements
The market for Sanger's sequencing services is expanding due to technological developments in sequencing methods, benefits of Sanger's sequencing, and an increase in genome mapping initiatives. Additionally, sequencing applications and R&D expenditure boost have added to the market's expansion.

Research and development (R&D) activities
The increased attention that vendors are paying to developing economies like China, India, and Southeast Asia is anticipated to promote market expansion. The market is expected to experience significant growth in the near future as a result of rising R&D spending and a boom in sanger sequencing applications.

Rise in genetic illness
The expanding use of genetic testing on vertebrates and plants, other factors influencing the market's growth include the rising prevalence and familiarity of genetic illnesses and tailored medicine. During the forecast period of 2022 to 2029, a few factors have the potential to propel market expansion.

Opportunities

A number of factors, including growing demand for affordable genotyping services, declining sequencing rates, technological advancements, and the growing need for pharmacogenomics in the development and advancement of medications, the Sanger sequencing market is predicted to grow at a healthy rate.

Some of the major players operating in the sanger sequencing market are:

Thermo Fisher Scientific Inc (U.S.)
Source BioScience (U.K.)
GenScript (U.S.)
LGC Limited (U.K.)
CeMIA (U.S.),
Quintara Biosciences (U.S.)
GenHunter Corporation (U.S.)
GENEWIZ (U.S.), Nucleics (U.K.)
SciGenom Labs Pvt. Ltd (India)
Microsynth AG (Switzerland)
Eurofins Scientific (Luxembourg)
LGC Limited (U.K.)
Fasteris SA (Switzerland)
StarSEQ GmbH (Germany)

Get PDF Sample:

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-sanger-sequencing-market

Sanger Sequencing Market Regional Analysis/Insights
The sanger sequencing market is analysed and market size insights and trends are provided by country, application, sequencing, laboratory, research, and end use as referenced above.

The countries covered in the sanger sequencing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the sanger sequencing market due to the rising number of geriatric population and innovative medical technology adoption.

Asia-Pacific (APAC) predicted to observe notable germination in the forecast period of 2022 to 2029, due to an expansion in research and development expenditure and a rise in the utilization of Sanger sequencing.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

More Links:

https://dbmrbuisness.blogspot.com/2023/07/global-blocking-buffers-market-industry.html

https://dbmrbuisness.blogspot.com/2023/07/global-primary-clostridioides-difficile.html

https://dbmrbuisness.blogspot.com/2023/07/global-temporal-arteritis-market.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.